The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.

The Journal of Biological Chemistry
Marco RusnatiMarco Presta

Abstract

Heparin binds extracellular HIV-1 Tat protein and modulates its HIV long terminal repeat (LTR)-transactivating activity (M. Rusnati, D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. d'Adda di Fagagna, M. Giacca, and M. Presta (1997) J. Biol. Chem. 272, 11313-11320). On this basis, the glutathione S-transferase (GST)-TatR49/52/53/55/56/57A mutant, in which six arginine residues within the basic domain of Tat were mutagenized to alanine residues, was compared with GST-Tat for its capacity to bind immobilized heparin. Dissociation of the GST-TatR49/52/53/55/56/57A.heparin complex occurred at ionic strength significantly lower than that required to dissociate the GST-Tat.heparin complex. Accordingly, heparin binds immobilized GST-Tat and GST-TatR49/52/53/55/56/57A with a dissociation constant equal to 0.3 and 1.0 microM, respectively. Also, the synthetic basic domain Tat-(41-60) competes with GST-Tat for heparin binding. Suramin inhibits [3H]heparin/Tat interaction, 125I-GST-Tat internalization, and the LTR-transactivating activity of extracellular Tat in HL3T1 cells and prevents 125I-GST-Tat binding and cell proliferation in Tat-overexpressing T53 cells. The suramin derivative 14C-PNU 145156E binds immobilized GST-Tat...Continue Reading

References

Jan 1, 1992·AIDS Research and Human Retroviruses·M O McClureR A Weiss
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J P TaylorS Amini
Jul 3, 1992·Science·J D PuglisiJ R Williamson
Feb 1, 1991·Journal of Virology·J M SabatierE Bahraoui
Jan 1, 1987·Antiviral Research·E De Clercq
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M BabaE De Clercq
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R GentzC A Rosen
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A BairdR Guillemin
Jul 1, 1987·Journal of Cellular Physiology·R J CoffeyH L Moses
Jan 20, 1994·Biochemical Pharmacology·M CiomeiN Mongelli
Oct 1, 1994·Journal of Neuroimmunology·F M HofmanS M Walker
Jan 1, 1995·Current Opinion in Oncology·M J Hawkins
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·A AlbiniB Ensoli
Feb 1, 1995·Trends in Pharmacological Sciences·T P FanR Bicknell
Jul 21, 1995·The Journal of Biological Chemistry·S R OpalenikJ A Thompson
Nov 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·G ZauliS Capitani
Dec 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M C ReM La Placa
Jan 1, 1994·Archives of Virology·L SteinaaJ E Hansen
Jul 1, 1994·AIDS Research and Human Retroviruses·L LopalcoA G Siccardi

❮ Previous
Next ❯

Citations

Apr 20, 2007·Pharmaceutical Research·Leena N PatelWei-Chiang Shen
Apr 20, 2001·The International Journal of Biochemistry & Cell Biology·F BussolinoB Ensoli
Dec 8, 2006·Human Gene Therapy·Hirofumi NoguchiShuji Hayashi
Feb 14, 2003·Journal of Virology·Ilia TikhonovC David Pauza
Jun 21, 2011·Journal of Biophysics·Fatemeh MadaniAstrid Gräslund
Oct 16, 2004·Molecular and Cellular Neurosciences·Gunnar P H Dietz, Mathias Bähr
May 27, 2006·Endothelium : Journal of Endothelial Cell Research·Marco Rusnati, Marco Presta
Nov 2, 2006·Expert Opinion on Drug Delivery·Christopher L Murriel, Steven F Dowdy
Nov 4, 2000·Expert Opinion on Investigational Drugs·L A Kueltzo, C R Middaugh
Sep 2, 2003·Journal of Pharmaceutical Sciences·Lisa A Kueltzo, C Russell Middaugh
Dec 24, 2015·Lasers in Surgery and Medicine·Johnny Chun-yin ChanHenry Hin-lee Chan
Jun 7, 2005·British Journal of Pharmacology·Simon W JonesMark A Lindsay
Aug 7, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rachel Tréhin, Hans P Merkle
Jul 1, 2006·Peptides·Dimitrios K NiarchosMichael Papamichail
Apr 19, 2015·Journal of Nanobiotechnology·Izzat Fahimuddin Bin Mohamed SuffianAkihiko Kondo
Oct 9, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabrizio SalomoneFabio Beltram
Oct 9, 2004·Biochimica Et Biophysica Acta·Marjan M FretzGert Storm
Mar 21, 2006·Biochimica Et Biophysica Acta·Sílvia PujalsErnest Giralt
May 14, 2016·Journal of Neurovirology·Pejman Rahimian, Johnny J He
Feb 22, 2005·Advanced Drug Delivery Reviews·Jehangir S Wadia, Steven F Dowdy
Feb 22, 2005·Advanced Drug Delivery Reviews·Hilary BrooksEric Vivès
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·N J CaronJ P Tremblay
May 15, 2004·Molecular & Cellular Proteomics : MCP·LaToya S JonesC Russell Middaugh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.